Related Experiment Video
Updated: Jan 14, 2026

Transcanalicular Diode Laser-assisted Dacryocystorhinostomy for the Treatment of Primary Acquired Nasolacrimal Duct Obstruction
Published on: October 13, 2017
External versus endonasal dacryocystorhinostomy: a single-centre United Kingdom study of 512 consecutive operations
Ziyaad N Sultan1, Nicholas Hickley1, Keri McLean2
1Aintree Hospital, Liverpool University Foundation Trust, Liverpool, UK.
Purpose:
To compare the surgical outcomes in patients undergoing elective external dacryocystorhinostomy (EX-DCR) and endonasal dacryocystorhinostomy (EN-DCR) for nasolacrimal duct obstruction (NLDO).
Methods And Materials:
Retrospective non-randomized comparative clinical study. Electronic patient records were used to identify patients that underwent surgery for NLDO from 2013-2019 at Aintree University Hospital, Liverpool. Data regarding the type of operative procedure, patient demographics, preoperative, perioperative, and postoperative examination findings were recorded.
Results:
Five hundred and twelve patients underwent DCR surgery (316 EX-DCR and 196 EN-DCR). The EX-DCR cohort median age was 70 (142 males, 176 females), and the EN-DCR median age was 62 (46 males, 149 females). For primary NLDO, symptomatic improvement in treatment-naïve patients was 90.7% (234/258) and 92.2% (141/153), for EX-DCR and EN-DCR, respectively. Revision surgery for failed primary NLDO, was successful in 89.8% (53/59) and 77.3% (34/44), for EX-DCR and EN-DCR respectively. Mean post-operative follow-up was 7.48 months. Complications were rare overall and included epistaxis and granuloma, 1.6% and 2.0%, respectively.
Conclusions:
Our overall surgical success rate at 90% (90.5% and 89.3% for EX-DCR and EN-DCR respectively) in primary NLDO are at the higher end of the spectrum of published data. Revision surgery is highly successful, and EX-DCR may be the preferred approach for revision surgery. Younger patients and females were more likely to undergo EN-DCR. Both surgical modalities are safe and complications rare.

